Introduction {#s1}
============

Many of the regulatory mechanisms controlling sleep have been deciphered in model organisms such as flies and mice, and appear to be conserved in humans ([@bib5]; [@bib19]; [@bib20]; [@bib43]; [@bib46]; [@bib51]; [@bib55]). These include dual regulation of sleep by the circadian clock and by homeostatic-drive, both of which are essential for maintaining regular sleep patterns ([@bib2]; [@bib5]). In *Drosophila*, a group of neurons which project to the dorsal layer of the fan-shaped body (dFB neurons) of the central complex in the brain is proposed to be one effector component of the sleep homeostat ([@bib14]; [@bib13]; [@bib32]). These dFB neurons receive inputs from Ellipsoid body R2 neurons, which encode sleep drive ([@bib32]) and suppress movements stimulated by sensory cues ([@bib15]). Other non-central complex neurons are also involved in sleep regulation and different neuronal pathways elicit distinct effects on the sleep homeostat ([@bib44]). Nevertheless, circadian pacemaker neurons that directly synapse onto dFB neurons have not yet been reported.

Sleep is essential for animal survival but comes with a large trade-off---other critical behaviors such as feeding, mating and defense only take place when an animal is awake ([@bib19]). Therefore, arousal-promoting molecules and neurons that stimulate wakefulness provide an essential balance. In *Drosophila*, various arousal signals have been identified and their functions in promoting wakefulness are conserved in mammals ([@bib10]; [@bib31]; [@bib43]; [@bib53]). These include biogenic amines (dopamine and octopamine) and neuropeptides such as Pigment Dispersing Factor (PDF) ([@bib3]; [@bib10]; [@bib11]; [@bib35]). Previous studies have demonstrated that dopamine can downregulate the activity of the dFB neurons ([@bib38]). Nevertheless, the anatomy of direct synaptic connections between dopaminergic neurons and dFB neurons is uncharacterized. It remains unknown whether different upstream neurons that regulate the activity of dFB neurons in opposite directions, synapse onto the same or distinct neurons in the dFB. Moreover, the behavioral consequences of simultaneous hyperactivation of sleep-promoting and wake-promoting neuronal circuits have not been investigated in animal models. An investigation of sleep behavior under such conditions may provide insights into sleep disorders due to uncoordinated activities of different sleep regulatory neurons.

Here we explore the sleep-regulatory neurons that function upstream of dFB neurons. We identified two groups of sleep-promoting neurons that form glutaminergic excitatory synaptic connections onto dFB neurons. One group of sleep-promoting neurons are circadian pacemaker neurons that also express the neuropeptide, Allatostatin-A (AstA), a sleep-promoting factor as well as a feeding regulator ([@bib7]; [@bib15]; [@bib22]). Additionally, we characterized synaptic connections from upstream dopaminergic arousal neurons onto the dFB neurons and revealed a novel wake-promoting mechanism by which dopamine released from arousal neurons inhibits synaptic output at the axonal terminals of dFB neurons. Lastly, we found that dFB neurons promote sleep by releasing GABA and inhibiting previously identified octopaminergic arousal (OAA) neurons ([@bib11]), thereby conferring long sleep bouts at night. Our results indicate that dFB neurons integrate different signals reflecting the circadian clock, arousal, as well as sleep drive. These signals originate from distinct populations of upstream neurons and converge on and influence the activity of common dFB neurons.

Results {#s2}
=======

Circadian (LPN) and SLP neurons promote sleep and function upstream of the sleep-homeostat {#s2-1}
------------------------------------------------------------------------------------------

To identify sleep-regulatory neurons that might function upstream of dFB neurons we employed the *Drosophila* Activity Monitoring system and scored sleep as inactivity for a minimum of 5 min, as previously described ([@bib36]; [@bib37]; [@bib46]). To assess the effects of chronically or acutely hyperactivating different classes of neurons, we used the *Gal4*/*UAS* system to express the depolarization-activated Na^+^ channel (NaChBac) ([@bib34]), or the red-shifted channelrhodopsin (CsChrimson) ([@bib29]). Control flies harboring *UAS-NaChBac* without any *Gal4* display typical sleep patterns characterized by minimal sleep at dawn and dusk (near ZT0 and ZT12, respectively), which rises to high levels during the middle of the day (near ZT6; [Figure 1A and E](#fig1){ref-type="fig"}). At night (ZT12---24), the control flies exhibit nearly maximal levels of sleep, which is 720 min ([Figure 1A and F](#fig1){ref-type="fig"}).

![Effects on sleep resulting from hyperactivation of dFB (*23E10*) and AstA (*65D05*) neurons.\
(**A---D**) Sleep profiles of the indicated flies during the day (ZT0---ZT12) and night (ZT12---ZT24). The white and black bars beneath the sleep profiles indicate the day and night cycles. The amounts of sleep (0---30 min) are plotted per 30 min bins. (**A**) Control flies (*UAS-NaChBac*/+). (**B**) Flies expressing *NaChBac* (*UAS-NaChBac*) using the *23E10-Gal4*. Note that the *23E10-Gal4* \> *NaChBac* annotation indicates transgenic flies that bear one copy of the *23E10-Gal4* transgene and one copy of the *UAS-NaChBac* transgene. Similar annotation applies elsewhere as all flies contain one copy each of the *UAS* and *Gal4* transgenes. (**C**) *65D05-Gal4* \> *NaChBac*. (**D**) Combined sleep profiles from A---C. (**E,F**) Quantification of daytime and nighttime sleep exhibited by the indicated flies. The genotypes are indicated below. (**G**) Bin crosses/min during the wake periods. The genotypes are indicated below. Error bars, SEMs. \*\*p\<0.01, one-way ANOVA with Dunnett's test. n = 16 for *UAS-NaChBac*/+, *n* = 48 for *23E10-Gal4*/+, n = 35 for *23E10-Gal4* \> *NaChBac*, and n = 30 for *65D05-Gal4* \> *NaChBac*. (**H**) Illustration of the *AstA^LexA^* allele containing the *LexA* gene inserted at the position of the normal translation start codon for *AstA*. The numbers indicate the genomic nucleotide residues, with one defined as the first nucleotide of the start codon of the wild-type *AstA* gene. (**I,J**) Whole-mount *AstA^+^* + *AstA^LexA^* brains stained with anti-AstA. The scale bars represent 40 µm. (**K**) Sleep profiles of flies exposed to optogenetic stimulation with CsChrimson. Flies were entrained under 12 hr blue light/12 hr dark cycles for 3 days, and then shifted to a red light/dark cycle on the 4^th^ day. Blue light does not activate CsChrimson. Shown are the sleep profiles under the blue and red light conditions as indicated by the blue and red bars. The total sleep time (0---30 min) is plotted in 30 min bins. The genotypes are indicated below. The flies include one copy of each of the indicated transgenes. *LexOp-CsChrimson*/+and *UAS-CsChrimson*/+were expressed under control of either the *AstA^LexA^*/+or *65D04-Gal4*/+, respectively. (**L**) Quantification of the change in daytime and nighttime sleep induced by CsChrimson activation. *AstA^LexA^*/*+*serves as the control. n = 10--32. Error bars, SEMs. \*\*p \< 0.01, one-way ANOVA with Dunnett's test. n = 32 for *AstA^LexA^*/*+*, *n* = 10 for *AstA^LexA^* \>*CsChrimson*, n = 70 for *65D05-Gal4* \> *CsChrimson*, and n = 23 for *AstA^LexA^* \>*CsChrimson* and *65D05-Gal4 \> TNT.*.](elife-40487-fig1){#fig1}

Hyperactivation of dFB neurons using *UAS-NaChBac* and the *23E10-Gal4* ([@bib15]; [@bib38]), which includes an enhancer from the *Allatostatin-A receptor 1* (*AstA-R1*) gene, greatly increases daytime sleep to levels that normally occur at night ([Figure 1B,D,E and F](#fig1){ref-type="fig"}). Consistent with a previous report ([@bib7]), we found that hyperactivation of neurons with *UAS-NaChBac* and *65D05-Gal4* (a *Gal4* containing an enhancer from the *AstA* gene) phenocopied the sleep-promoting effects caused by hyperactivating dFB neurons with NaChBac ([Figure 1C,D and E](#fig1){ref-type="fig"}). The neuronal hyperactivation with NaChBac did not impair locomotion since the levels of activity during the wake periods were similar between the control flies and the animals expressing *UAS-NaChBac* ([Figure 1G](#fig1){ref-type="fig"}).

Flies that are in a sleep-like state have increased arousal thresholds similar to other animals ([@bib21]; [@bib46]). Therefore, to provide evidence that the decreased activity due to hyperactivation of *65D05-Gal4*-expressing neurons reflects an increase in sleep, we applied a simple arousal paradigm. We maintained the flies for five days under 12 hr light/12 hr dark cycles. On the fifth night, we exposed the flies to three light-pulses (5 min each delivered at ZT16, ZT18, and ZT20; [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). In control flies (*65D05-Gal4/+* and *UAS-NaChBac*/*+*), the light stimuli caused large reductions in sleep during the 30-min period following the onset of the light stimuli ([Figure 1---figure supplement 1B---D](#fig1s1){ref-type="fig"}). However, the *65D05 *\> *NaChBac* flies did not exhibit decreased sleep (arousal) in response to the 5 min light stimulations ([Figure 1---figure supplement 1B and E](#fig1s1){ref-type="fig"}). These data support the proposal that hyperactivation of *65D05-Gal4* positive neurons increases sleep. dFB neurons were proposed to secrete the AstA peptide based on AstA-positive immunostaining around the terminals of dFB neurons ([@bib15]). However, the AstA-expressing neurons are most likely adjacent to rather than the dFB neurons themselves since dFB neurons are not labeled by any of the previously described *AstA* reporters ([@bib7]; [@bib22]). Rather, dFB neurons are labeled by the *23E10-Gal4*, which is an AstA-receptor (AstA-R1) reporter ([@bib26]). Since hyperactivation of neurons labeled by the *AstA* reporter (*65D05-Gal4*) leads to sleep-promoting effects that are similar to those that result from hyperactivation of dFB neurons, which are labeled by the *AstA-R1* reporter, we hypothesize that the neurons that are marked by *AstA* reporter (*65D05-Gal4*) function in the same sleep-promoting pathway as the dFB neurons.

To facilitate the identification of sleep-promoting neurons labeled by the *AstA* reporter, *65D05-Gal4*, we used CRISPR/Cas9-mediated gene editing to replace the coding region with a *LexA* reporter (*AstA^LexA^; [Figure 1H](#fig1){ref-type="fig"}*), so that we could use *LexA* to perform double-labeling with existing *Gal4* reporters. The *AstA^LexA^* flies also provided a null allele, which is useful since the currently available line is a hypomorphic mutant ([@bib14]; [@bib15]). As expected, the *AstA^LexA^* mutation eliminated anti-AstA staining in the brain ([Figure 1I and J](#fig1){ref-type="fig"}).

To verify that the *AstA^LexA^* reporter indeed labels sleep-promoting neurons, we expressed CsChrimson under control of the *AstA^LexA^* reporter (*AstA^LexA^*/+) so that *AstA^LexA^*-positive neurons could be activated with red lights. We used heterozygous *AstA^LexA^*/+flies since *AstA^LexA^* is a null allele. Activation of *AstA^LexA^*-positive neurons (*AstA^LexA^* \>*CsChrimson*) led to an increase in daytime sleep ([Figure 1K and L](#fig1){ref-type="fig"}). However, the increase was less pronounced than with the *65D05-Gal4* reporter ([Figure 1K and L](#fig1){ref-type="fig"}).

The *65D05-Gal4* reporter labeled several regions in the brain, including sensory processing regions such as the medulla layer of the optical lobe (med) and the primary gustatory center, the subesophageal zone (SEZ; [Figure 2A and B](#fig2){ref-type="fig"}), similar to previously characterized *AstA-Gal4* reporter lines (*AstA^1^-Gal4* and *AstA^2^-Gal4*) ([@bib22]). However, the *AstA^LexA^* reporter labeled many fewer neurons ([Figure 2C](#fig2){ref-type="fig"}). By comparing the labeling with these two reporters we found that three neurons located in the lateral posterior region of the brain were labeled by both reporters (LPN^AstA^; [Figure 2B and C](#fig2){ref-type="fig"}). The positions of these neurons resemble a group of circadian pacemaker neurons termed lateral posterior neurons (LPNs) ([@bib45]). The contributions of LPNs to sleep have not been reported previously. We confirmed the identity of the LPNs by co-staining with Timeless (Tim; [Figure 2D---F](#fig2){ref-type="fig"}) and Period (Per; [Figure 2G---I](#fig2){ref-type="fig"}), two core clock proteins expressed in *Drosophila* circadian pacemaker neurons ([@bib39]; [@bib42]). These LPNs also express the AstA peptide and are referred to here as LPN^AstA^ neurons ([Figure 2J---L](#fig2){ref-type="fig"}).

![LPN^AstA^ circadian pacemaker neurons are labeled by *AstA* reporters (*65D05-Gal4* and *AstA^LexA^*) and anti-AstA.\
(**A**) Whole-mount of a brain expressing *UAS-mCD8::GFP* under the control of the *65D05-Gal4*. Green, anti-GFP; blue: anti-nc82 (a pan-neuronal marker labeling active zones). The dashed box indicates the region shown at higher magnification in B. The scale bar represents 40 µm. (**B**) Zoomed-in view of boxed region in **A**. The arrow and arrowhead indicate SLP^AstA^ and LPN^AstA^ neurons, respectively. The scale bar represents 20 µm. (**C**) Immunostaining of a brain whole-mount (*AstA^LexA^* \>*mCD8::GFP*) with anti-GFP (green) and anti-nc82 (magenta) The scale bar represents 40 µm. The inset at the right bottom corner shows the three LPN^AstA^ neurons. (**D---L**) Immunostaining of LPN^AstA^ neurons in brain whole-mounts from *65D05-Gal4* \> *mCD8::GFP* flies. (**D---F**) Co-staining with anti-GFP (green) and anti-Tim (magenta). The scale bar represents 10 µm. (**G---I**) Co-staining with anti-GFP (green) and anti-Per (magenta). The scale bar represents 10 µm. (**J---K**) Co-staining with anti-GFP (green) and anti-AstA (red), the scale bar represents 10 µm.](elife-40487-fig2){#fig2}

We tested whether LPN^AstA^ are the key *AstA^LexA-^*positive neurons required for promoting sleep by using tetanus toxin to inhibit neurotransmission from LPN^AstA^ neurons while activating the remaining *AstA^LexA^* neurons. To do so, we took advantage of the observation that the only neurons labeled by both the *65D05-Gal4* and *AstA^LexA^* reporters are LPN^AstA^ neurons. Therefore, we introduced the *65D05-Gal4 and UAS-tetanus toxin* (*TNT*) ([@bib47]) into the *AstA^LexA^*/+* \> CsChrimson* background. We treated these animals with red lights and found that the sleep-promoting effect induced in *AstA^LexA^*/+* \> CsChrimson* flies was abolished ([Figure 1K and L](#fig1){ref-type="fig"}). Based on this evidence we conclude that LPN^AstA^ neurons are sleep-promoting circadian pacemaker neurons.

Because the increase in sleep caused by light activation of neurons in *AstA^LexA^*/+* \> CsChrimson* flies was less robust than in *65D05-Gal4 \> CsChrimson* flies ([Figure 1K and L](#fig1){ref-type="fig"}), it is plausible that a second group of sleep-promoting neurons are labeled by the *65D05-Gal4* but not the *AstA^LexA^* reporter. To test this possibility, we examined the sleep promoting effects resulting from hyperactivation of all neurons labeled by the *65D05-Gal4* except the LPN^AstA^ neurons. We expressed *UAS-NaChBac* under the control of the *65D05-Gal4*, and in the same flies expressed *Gal80* under the control of *AstA^LexA^* to inhibit Gal4 activity in LPN^AstA^ neurons. We still observed sleep-promoting effects in these transgenic animals including increased total daytime sleep and sleep bout length ([Figure 1---figure supplement 2A---C, E---G](#fig1s2){ref-type="fig"}). The sleep-promoting effects displayed by these flies were smaller than without the *Gal80* expression in LPN^AstA^ neurons ([Figure 1---figure supplement 2D---G](#fig1s2){ref-type="fig"}). Together, these findings support the model that LPN^AstA^ and additional neurons marked by the *65D05-Gal4* reporter promote sleep.

To identify the additional group of sleep-promoting neurons labeled by the *65D05-Gal4*, we used a genetic '*FlpOut*' approach to generate flies expressing the warm-activated cation channel TRPA1 tagged with mCherry in different subgroups of neurons labeled by the *65D05-Gal4* ([Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}). To visualize the key sleep-promoting neurons, we compared the expression patterns of *mCherry::trpA1* in the brains of flies that did not show an increase in total sleep with the staining patterns from flies that showed significant increases in sleep upon thermoactivation. Neurons located in the medullar layer (med) of the optic lobe and the SEZ did not show differential expression between the two groups of flies, indicating that they are not the sleep-promoting neurons ([Figure 3---figure supplement 1E---H](#fig3s1){ref-type="fig"}). In contrast, we found that neurons located in the superior lateral protocerebrum (SLP) were stained positive by mCherry only in flies exhibiting an increase in sleep ([Figure 3---figure supplement 1I and J](#fig3s1){ref-type="fig"}). LPN^AstA^ neurons stained strongly with mCherry in flies that showed significantly higher levels of sleep, and stained weakly in flies that did not show an increase in sleep ([Figure 3---figure supplement 1I and J](#fig3s1){ref-type="fig"}). These data indicate that SLP^AstA^ neurons are a second group of sleep-promoting neurons labeled by *65D05-Gal4*.

Next, we tested if neuronal activity in the dFB was required for LPN^AstA^ and SLP^AstA^ neurons to promote sleep. To do so, we monitored sleep in flies in which we activated LPN^AstA^ and SLP^AstA^ neurons and tested the effects of this activation after suppressing neurotransmission from dFB neurons. To stimulate LPN^AstA^ and SLP^AstA^ neurons, we expressed CsChrimson (*LexOp-CsChrimson*) using a *65D05-LexA* reporter (constructed with the same DNA regulatory sequences as the *65D05-Gal4*), which also labels LPN^AstA^ and SLP^AstA^ neurons similar to the *65D05-Gal4* ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). To maintain flies under 12 hr light/12 hr dark cycles without stimulating the red-light activated CsChrimson, we exposed the flies to blue light during the 12 hr light periods for 3 days. On the 4^th^ day, we replaced the blue with red lights to stimulate the neurons. As expected, red light induced an increase in daytime sleep and consolidated daytime sleep into longer bouts ([Figure 3A---F](#fig3){ref-type="fig"}). However, when we blocked neurotransmission from dFB neurons with TNT (*23E10-Gal4* and *UAS-TNT*), optogenetic activation of LPN^AstA^ and SLP^AstA^ neurons no longer promoted sleep or sleep bout consolidation ([Figure 3A---F](#fig3){ref-type="fig"}). Taken together, we identified two groups of neurons, which promote sleep and appear to function presynaptic to dFB neurons. The finding that one of the groups of neurons are *bona fide* circadian pacemaker neurons suggests a direct neuronal pathway through which the circadian system regulates the sleep homeostat.

![Anatomical and functional connectivity between LPN^AstA^/SLP^AstA^ and dFB neurons.\
(**A---D**) Sleep profiles of the indicated flies under 12 hr blue light/12 hr dark and 12 hr red light/12 hr dark cycles. Red but not blue lights activate CsChrimson. (**E**) Quantification of changes in daytime and nighttime sleep due to neuronal activation by red lights in *65D05* neurons expressing CsChrimson. (**F**) Quantification of changes in daytime and nighttime sleep bout length due to neuronal activation by red lights in *65D05* neurons expressing CsChrimson. The changes in total sleep time and the average bout lengths were calculated by subtracting these sleep parameter values obtained during the blue-light/dark cycles from those obtained during the red-light/dark cycles. Error bars, SEMs. \*\*p \< 0.01, one-way ANOVA with Dunnett's test. n = 15 for *lexAOp-CsChrimson*/+, n = 24 for *65D05-LexA* \> *CsChrimson*, and n = 31 for *65D05-LexA* \> *CsChrimson* and *23E10-Gal4* \> *TNT*. (**G**) Anti-tdTomato (magenta) and anti-GFP (green) staining of a whole-mount brain expressing tdTomato in dFB neurons (*23E10-LexA* \> *tdTom*) and GFP in SLP^AstA^ neurons (*65D05-Gal4* \> *GFP*). Both reporters showed innervation in the SMP. The scale bar represents 20 µm. (**H**) Anti-tdTomato (magenta) and anti-GFP (green) staining of a whole-mount brain expressing tdTomato in dFB neurons and GFP in LPN^AstA^ neurons (*AstA^LexA^* \>*GFP*). Both reporters stained the SMP region. The scale bar represents 40 µm. (**I**) Cartoon illustrating the GRASP assay. Fluorescence is produced only when the two segments of GFP associate on the extracellular surfaces of adjacent cells. (**J**) Image of GRASP GFP fluorescence revealing close association between *65D05-Gal4* and *AstAR1-LexA* labeled neurons in the brain. The scale bar represents 60 µm. (**K**) Representative images of GCaMP3 fluorescence in dFB neurons upon activating the ATP-gated P2X2 cation channel in LPN^AstA^ and SLP^AstA^ neurons (*65D05-Gal4* \> *P2X2*) Shown are images before and during application of the imaging buffer (AHL) only, or ATP (2.5 mM final concentration) in imaging buffer. The scale bars represent 20 µm. (**L**) Quantification of the changes in GCaMP3 fluorescence in dFB neurons before and after adding the imaging buffer only or during exposure to 2.5 mM ATP to activate P2X2 expressing neurons. The effects of adding ATP versus the imaging buffer only were compared. Error bars, SEM. \*\*p\<0.01, unpaired Student's *t*-test. n = 14 for ATP treatment and 16 for treatment with the imaging buffer from three independent imaging experiments.](elife-40487-fig3){#fig3}

SLP^AstA^ and LPN^AstA^ neurons form close associations and function presynaptic to dFB neurons {#s2-2}
-----------------------------------------------------------------------------------------------

To address whether SLP^AstA^ and LPN^AstA^ neurons form close associations with dFB neurons, we performed double-labeling experiments. We examined the relative positions of the projections of SLP^AstA^, LPN^AstA^ and dFB neurons by expressing different fluorescent reporters. Both SLP^AstA^ and LPN^AstA^ neurons send their projections to the superior median protocerebrum (SMP) region, which is also innervated by projections from dFB neurons ([Figure 3G and H](#fig3){ref-type="fig"}), indicating the potential for a direct neuronal connectivity.

We then used GFP reconstitution across synaptic partners (GRASP) ([@bib16]; [@bib17]) to test if these two sets of sleep-promoting neurons form close associations. In this approach two non-functional fragments of membrane tethered GFP (mCD4-GFP^1-10^ and mCD4-GFP^11^) are expressed on the extracellular surfaces of different neurons. GFP fluorescence is reconstituted only if the two fragments are brought into contact, such as when the terminals of the two neurons associate closely ([Figure 3I](#fig3){ref-type="fig"}). Consistent with our double-labeling experiments ([Figure 3G and H](#fig3){ref-type="fig"}), we detected GFP fluorescence in the SMP region of the brain where LPN^AstA^, SLP^AstA^ (expressing *65D05-Gal4* \> *UAS-mCD4-GFP^1-10^*) and dFB neurons (expressing *23E10-LexA* \> *lexAOp-mCD4-GFP^11^*) send their projections ([Figure 3J](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1K and L](#fig3s1){ref-type="fig"}).

To investigate functional connectivity, we expressed the ATP-activated cation channel P2X2 (*UAS-P2X2*) ([@bib57]) in SLP^AstA^ and LPN^AstA^ neurons under control of the *65D05-Gal4*, and monitored changes in the activity of dFB neurons with GCaMP3 (*UAS-GCaMP3*), a genetically encoded Ca^2+^ indicator ([@bib49]). After applying ATP to activate the SLP^AstA^ and LPN^AstA^ neurons, there was a significant increase in GCaMP3 fluorescence in dFB neurons relative to applying the imaging buffer only ([Figure 3K and L](#fig3){ref-type="fig"}).

Glutamate is a sleep-promoting neurotransmitter used by LPN^AstA^ and SLP^AstA^ to activate dFB neurons {#s2-3}
-------------------------------------------------------------------------------------------------------

Based on the results described above we propose the existence of sleep-promoting excitatory synaptic connections from LPN^AstA^ and SLP^AstA^ neurons to the downstream dFB neurons. To identify the relevant neurotransmitter, we used RNAi to knock-down genes essential for the synthesis or packaging of various neurotransmitters. These include the vesicular glutamate transporter (*VGlut*) ([@bib12]), the vesicular monoamine transporter (*VMAT*) ([@bib18]), choline acetyltransferase (*ChAT*) ([@bib24]) and glutamic acid decarboxylase 1(*Gad1*) ([@bib25]).

To screen for RNAi lines that lead to a large reduction of target gene expression, we expressed a panel of available RNAi transgenes targeting the above genes with the pan-neuronal reporter *elav-Gal4*. We used a *VGlut-RNAi* line and a *VMAT-RNAi* line that lead to substantial reductions of target gene expression ([Figure 4---figure supplement 1A---F](#fig4s1){ref-type="fig"} and Methods). For *ChAT* and *Gad1* we selected the RNAi lines that lead to lethality when expressed pan-neuronally, which is indicative of effective abolition of acetylcholine and GABA synthesis since they are essential neurotransmitters.

We first expressed these RNAi transgenes in flies expressing *UAS-NaChBac* under control of the *65D05-Gal4*, which results in hyperactivation of *AstA*-positive neurons, including LPN^AstA^ and SLP^AstA^ neurons (*65D05* \> *NaChBac* and RNAi). We found that the increase in sleep due to hyperactivation by NaChBac (*65D05* \> *NaChBac*) was reduced when RNAi was directed against *VGlut*---the transporter required for packaging glutamate in synaptic vesicles ([Figure 4A and F](#fig4){ref-type="fig"}). In contrast, the elevation in sleep induced by NaChBac was not affected when we used RNAi to knockdown genes required for the synthesis or packaging of other major neurotransmitters including acetylcholine (*ChAT*), γ-aminobutyric acid (GABA; *Gad1*) and biogenic amines (*VMAT*) ([Figure 4B---F](#fig4){ref-type="fig"}). These observations suggest an important role for glutamate in conferring the sleep-promoting contributions of LPN^AstA^ and SLP^AstA^ neurons.

![Glutamate is the excitatory neurotransmitter in *65D05-Gal4*-positive neurons, which activates dFB neurons and promotes sleep.\
(**A**) Sleep profile of *65D05-Gal4* \> *NaChBac* flies with and without the *VGlut RNAi* (*UAS-VGlut*) expressed under control of the *65D05-Gal4*. (**B---D**) Sleep profiles of *65D05-Gal4* \> *NaChBac* flies expressing *VMAT-RNAi*, *ChAT-RNAi or Gad1-RNAi* transgenes under control of the *65D05-Gal4*. (**E**) Combination of sleep profiles shown in **A---D**. (**F**) Quantification of daytime and nighttime sleep of *65D05-Gal4* \> *NaChBac* flies expressing the indicated RNAi lines. Error bars, SEM. \*\*p\<0.01, one way ANOVA with Dunnett's test. n = 85 for no RNAi, n = 51 for *VGlut* RNAi, n = 42 for *VMAT RNAi*, n = 46 for *ChAT RNAi*, and n = 40 for *Gad1 RNAi*. (**G**) Representative images of GCaMP6f fluorescence before and after bath application of 50 mM glutamate. (**H**) Representative traces of changes in GCaMP6f fluorescence (∆F/F~0~) upon bath application of 50 mM glutamate. (**I**) Representative images of GCaMP6f fluorescence before and after bath application of 50 mM acetylcholine. (**J**) Representative traces showing changes in GCaMP6f fluorescence (∆F/F~0~) upon bath application of 50 mM acetylcholine. The scale bars in panels **G** and **I** represent 20 µm.](elife-40487-fig4){#fig4}

To investigate the role of glutamate in basal sleep, we expressed the *VGlut-RNAi* without neuronal hyperactivation (no NaChBac expression). While overall sleep time was unaffected ([Figure 4---figure supplement 1G and H](#fig4s1){ref-type="fig"}), knocking down *VGlut* in *65D05-Gal4* positive neurons increased fragmented nighttime sleep as indicated by a significant reduction of nighttime sleep bout length ([Figure 4---figure supplement 1J](#fig4s1){ref-type="fig"}). The small reduction in daytime sleep bout length was not statistically significant ([Figure 4---figure supplement 1I](#fig4s1){ref-type="fig"}). A greater reduction of sleep bout length (both day and night) occurred when we hyperpolarized (*65D05 \> kir2.1*) or blocked neurotransmission (*65D05 \> TNT*) from SLP^AstA^ and LPN^AstA^ neurons ([Figure 4---figure supplement 1K and L](#fig4s1){ref-type="fig"}).

To test whether the dFB neurons respond to glutamate, we employed an ex-vivo brain preparation amenable to imaging neuronal activity in freshly dissected brains. We expressed a fluorescent Ca^2+^ sensor (*UAS-GCaMP6f*) ([@bib6]) to image the activities of dFB neurons after applying glutamate to the bath. We found that addition of glutamate caused an increase in GCaMP6f fluorescence ([Figure 4G and H](#fig4){ref-type="fig"}). In contrast, these neurons did not respond to acetylcholine---another major excitatory neurotransmitter in the *Drosophila* brain ([Figure 4I and J](#fig4){ref-type="fig"}).

Sleep-promoting role of AstA and a central clock component in LPN^AstA^ neurons {#s2-4}
-------------------------------------------------------------------------------

LPN^AstA^ neurons express both the neuropeptide AstA and central clock genes ([Figure 2D---L](#fig2){ref-type="fig"}). To test for a potential contribution of the central clock for the sleep-promoting function of LPN^AstA^ neurons we expressed a dominate-negative isoform of the clock component, Clock (*UAS-Clk∆*) ([@bib48]) in LPN^AstA^ neurons under control of the *65D05-Gal4*. We found that the sleep-promoting effect of neuronal hyperactivation of LPN^AstA^ neurons (*65D05-Gal4 \> NaChBac*) during the daytime was reduced by expression of *Clk∆* ([Figure 4---figure supplement 2A and B](#fig4s2){ref-type="fig"}). This indicates that the central clock in LPN^AstA^ neurons contributes to the sleep promoting function of these neurons.

To address whether AstA functions in LPN^AstA^ neurons to promote sleep, we examined whether removal of AstA impacted on the sleep-promoting effect induced by hyperactivation of these neurons (*65D05-Gal4 \> NaChBac*). We found that the *AstA^LexA^* mutation significantly decreased the sleep-promoting effect caused by expression of NaChBac ([Figure 4---figure supplement 2C and D](#fig4s2){ref-type="fig"}). The reduction in sleep due to the *AstA^LexA^* mutation was most pronounced during the second half of the daytime period. These results indicate that in addition to glutamate ([Figure 4A](#fig4){ref-type="fig"}) AstA also contributes to the sleep-promoting function of LPN^AstA^ neurons.

Synaptic inputs from sleep- and arousal-promoting neurons target different dFB projections {#s2-5}
------------------------------------------------------------------------------------------

Dopamine is released by tyrosine hydroxylase (TH)-expressing neurons and is an arousal-promoting molecule ([@bib31]; [@bib38]; [@bib53]), which inhibits the activity of dFB neurons ([Figure 5---figure supplement 1A and B](#fig5s1){ref-type="fig"}). We imaged the relative innervation patterns of dopamine arousal (DAA) neurons and dFB neurons to address whether they were in close association. We labeled dFB neurons with tdTomato (*23E10-LexA* \> *tdTomato; [Figure 5A](#fig5){ref-type="fig"}* and *B*), and DAA neurons with a GFP reporter (*TH-Gal4* \>*GFP*, [Figure 5A and B](#fig5){ref-type="fig"}), which was expressed in a majority of neurons that stained with anti-TH ([Figure 5---figure supplement 1C---E](#fig5s1){ref-type="fig"}). The soma of the DAA and dFB neurons were distinct, although many were juxtaposed ([Figure 5---figure supplement 1F](#fig5s1){ref-type="fig"}). We found that the DAA neurons project to two layers within the FB: the dorsal FB layer (dFB) and the ventral FB layer (vFB; [Figure 5B](#fig5){ref-type="fig"}). The dorsal layer innervation of DAA neurons overlapped with the projections from dFB neurons ([Figure 5B](#fig5){ref-type="fig"}), suggesting possible synaptic connection between DAA and dFB neurons.

![Dopaminergic arousal (DAA) neurons associate closely with dFB neurons and downregulate their activity.\
(**A, B**) Brains expressing GFP in dopaminergic neurons (*TH-Gal4* \>*GFP*) and tdTomato in dFB neurons (*23E10-LexA* \> *tdTomato*) stained with anti-GFP (green), anti-tdTomato (magenta) and anti-nc82. The dFB and vFB regions are indicated in B. The scale bars represent 60 and 20 µm in A and B, respectively. (**C**) GRASP GFP fluorescence revealing close associations between sleep-promoting dFB neurons and dopaminergic neurons in the brain. The dFB (*23E10-LexA* positive) and dopaminergic neurons (*TH-Gal4* positive) expressed the GFP^11^ and GFP^1-10^ fragments, respectively. The scale bar represents 60 µm. (**D**) Representative images of GCaMP3 fluorescence in dFB neurons (*23E10-LexA* positive) upon activating the ATP-gated P2X2 cation channel (*UAS-P2X2*) expressed in DAA neurons under control of the *TH-Gal4*. Shown are images before and during application of the imaging buffer (AHL) only, or ATP (2.5 mM final concentration) in the imaging buffer. The scale bars represent 20 µm. (**E**) Quantification of the changes in GCaMP3 fluorescence in dFB neurons before and after adding the imaging buffer (AHL) only or during exposure to 2.5 mM ATP to activate P2X2 expressing DAA neurons. The genotype of the flies is as indicated in (**D**). \*\*p \< 0.01. Unpaired Student's *t*-test. n = 24 for ATP treatment and n = 26 for treatment with the imaging buffer only from three independent imaging experiments. (**F**) Cartoon showing the positions of the dendrites and axons of LPN^AstA^/SLP^AstA^ neurons and DAA neurons relative to the processes of the dFB neurons. (**G, H**) Whole-mount brain expressing dendritic (*UAS-DenMark*) and axonal (*UAS-syt-eGFP*) markers in dFB neurons under control of the *23E10-Gal4*. The brain was stained with anti-dsRed and anti-GFP to detect DenMark and syt::eGFP, respectively, and with anti-nc82. The boxed region in (**G**) indicates the superior medial protocerebrum (SMP). The scale bars represent 40 µm. (**I**) Representative images showing syt::GCaMP6s fluorescence in axonal terminals of dFB neurons before the after bath application of 10 mM dopamine. *UAS-syt::GCaMP6s* was expressed in dFB neurons under control of the *23E10-Gal4*. The scale bar represents 20 µm. (**J**) Representative trace showing the change in syt::GCaMP fluorescence (∆F/F~0~) in axons of dFB neurons (*23E10-Gal4* \> *syt::GCaMP6s*) upon bath application of 10 mM dopamine.](elife-40487-fig5){#fig5}

We used GRASP to assess whether the DAA and dFB neuronal membranes were in close proximity, which would support a model that they make synaptic connections. To test this possibility, we imaged brains from flies expressing two fragments of GFP (*UAS-CD4::spGFP^1-10^* and *lexAOp-CD4::spGFP^11^*) under the control of the *TH-Gal4* and the *23E10-LexA* ([Figure 5---figure supplement 1G](#fig5s1){ref-type="fig"}). We observed GRASP signals in regions of the brain containing dFB neuronal projections, including the SMP region and the dFB ([Figure 5C](#fig5){ref-type="fig"}). We did not detect GFP signals in brains expressing only one of the two GFP fragments ([Figure 3---figure supplement 1L](#fig3s1){ref-type="fig"} and [Figure 5---figure supplement 1H](#fig5s1){ref-type="fig"}).

To determine if activation of DAA neurons inhibits dFB neurons, we expressed the ATP-activated cation channel P2X2 in DAA neurons (*TH-Gal4* \>*P2X2*) and monitored changes in the activity of dFB neurons with GCaMP3 (*23E10-LexA* \> *GCaMP3*). After applying ATP, we observed a significant reduction (p \< 0.01, unpaired Student's *t*-test) in GCaMP3 fluorescence relative to the effect of applying the imaging buffer only ([Figure 5D and E](#fig5){ref-type="fig"}).

While LPN^AstA^ and SLP^AstA^ sleep promoting neurons only synapse onto the SMP projections of dFB neurons, DAA arousal neurons synapse onto both the SMP projections and the dorsal layer projections of dFB neurons ([Figure 5F](#fig5){ref-type="fig"}). To characterize these synaptic inputs further, we imaged the relative dendritic and axonal locations of dFB neurons by expressing both a dendritic marker (*UAS-DenMark*) and an axonal marker (*UAS-syt::eGFP*) ([@bib33]) under control of the dFB reporter (*23E10-Gal4*). We found that SMP projections of dFB neurons were more intensively marked by DenMark, while the dorsal layer projections of dFB neurons were more heavily labeled with syt::eGFP ([Figure 5G and H](#fig5){ref-type="fig"}). Therefore, we propose that dFB neurons receive upstream inputs mainly through synapses in the SMP area stemming from sleep-promoting LPN^AstA^ and SLP^AstA^ neurons. Furthermore, these data suggest that the dFB neurons transmit signals through axonal terminals located in the dorsal FB layer.

One possible role of the synaptic connections from DAA neurons to the axonal terminals of dFB neurons is pre-synaptic regulation of dFB neuronal output. Therefore, we asked if dopamine suppresses Ca^2+^ dynamics in axonal terminals of dFB neurons located in the dorsal layer, thereby negatively regulating the output from dFB neurons. To test this idea, we imaged Ca^2+^ dynamics locally in the axonal terminals of dFB neurons. To do so, we expressed syt::GCaMP6s ([@bib9]) (a protein consisting of synaptotagmin fused to GCaMP6s) in dFB neurons and performed imaging using an ex-vivo brain preparation. When we applied dopamine to the bath, we observed a reduction in Ca^2+^levels in the axonal terminals of the dFB neurons ([Figure 5I and J](#fig5){ref-type="fig"}). In contrast, application of either of two other major invertebrate biogenic amines (octopamine and tyramine) did not change the Ca^2+^dynamics in dFB neurons ([Figure 5---figure supplement 1I](#fig5s1){ref-type="fig"}).

Effect of simultaneous activation of dFB and DAA neurons {#s2-6}
--------------------------------------------------------

Since the activity of dFB neurons are regulated by LPN^AstA^/SLP^AstA^ neurons and DAA neurons in opposite directions, we tested the effects on sleep when these two groups of dFB regulatory neurons (LPN^AstA^/SLP^AstA^ and DAA neurons) were activated simultaneously. Activating DAA neurons (*TH-Gal4* \>*NaChBac*) led to a drastic reduction in total sleep time (158 ± 37 min), relative to the controls (849 ± 32 min for *UAS-NaChBac*/+and 982 ± 38 for*TH-Gal4*/+; [Figure 6A and B](#fig6){ref-type="fig"}). As described above, activating *65D05-Gal4* positive neurons (LPN^AstA^ and SLP^AstA^) promotes sleep (1343 ± 36 min; [Figure 6A and B](#fig6){ref-type="fig"}). Of significance, co-activating DAA and LPN^AstA^/SLP^AstA^ neurons with NaChBac led to a level of total sleep time (881 ± 46 min) similar to the control flies ([Figure 6A and B](#fig6){ref-type="fig"}).

![Hyperactivation of dopaminergic neurons antagonizes the sleep-promoting effect of hyperactivation of LPN^AstA^ and SLP^AstA^ (*65D05-positive*) neurons.\
(**A**) Effects on sleep profiles due to hyperactivation of *TH-positive* (dopaminergic) and *65D05-positive* (includes LPN^AstA^ and SLP^AstA^ neurons) with NaChBac. See the legend at the bottom right for the genotypes. (**B**) Quantification of total sleep time during a 24 hr light/dark cycle by the flies indicated in (**A**). (**C---E**) Quantification of daytime and nighttime sleep and awake parameters in flies of the indicated genotypes. (**C**) Sleep bout length. (**D**) Sleep bout number. (**E**) Awake bout length. n = 12---24. Error bars, SEMs. \*p \< 0.05, \*\*p \< 0.01. One-way ANOVA with Dunnett's test. n = 16 for *TH-Gal4*/+, n = 47 for *65D05-Gal4*/+, n = 16 for *UAS-NaChBac*/+, n = 12 for *65D05-Gal4* \> *NaChBac*, n = 14 for *TH-Gal4* \>*NaChBac*, and n = 24 for *65D05-Gal4* and *TH-Gal4* \>*NaChBac*.](elife-40487-fig6){#fig6}

To characterize the consequences of co-activating DAA and LPN^AstA^/SLP^AstA^ neurons in greater detail, we analyzed two features of sleep patterns: sleep bout number and sleep bout length. When we only used the *65D05-Gal4* to express *NaChBac*, daytime sleep bouts were significantly lengthened ([Figure 6C](#fig6){ref-type="fig"}). Conversely, activating DAA neurons (*TH \>NaChBac*) resulted in fragmented sleep with a significantly reduced sleep bout length, which was most obvious for nighttime sleep ([Figure 6C](#fig6){ref-type="fig"}). When we simultaneously activated LPN^AstA^/SLP^AstA^ and DAA neurons with the *65D05-Gal4* and *TH-Gal4*, respectively, the sleep bouts were shorter than those exhibited by the control but were comparable to flies in which only the DAA neurons were activated (*TH \>NaChBac; [Figure 6C](#fig6){ref-type="fig"}*). Additionally, activating both LPN^AstA^/SLP^AstA^ and DAA neurons caused the flies to initiate many more sleep episodes, as indicated by a significant increase in the sleep bout number ([Figure 6D](#fig6){ref-type="fig"}).

We then compared the episodes of wakefulness of these flies. In control flies, wake bout length is much longer during the day than night ([Figure 6E](#fig6){ref-type="fig"}). Activating sleep-promoting LPN^AstA^/SLP^AstA^ neurons (*65D05-Gal4* \> *NaChBac*) led to a reduction in the bout length of daytime wakefulness, while activating arousal-promoting DAA neurons increased the bout length of nighttime wakefulness ([Figure 6E](#fig6){ref-type="fig"}). Remarkably, when the two groups of neurons were activated simultaneously, both daytime and nighttime activities were fragmented ([Figure 6E](#fig6){ref-type="fig"}).

GABA production is required in dFB neurons to promote sleep {#s2-7}
-----------------------------------------------------------

To screen for the neurotransmitter synthesized in dFB neurons that is essential for conveying sleep-promoting signals, we silenced expression of genes required for neurotransmitter synthesis or packaging. Thermoactivation of dFB neurons with TRPA1 (*23E10* \> *trpA1*) enhances sleep ([Figure 7A, B, D---F](#fig7){ref-type="fig"}). However, this effect was eliminated when we used RNAi to knockdown *Gad1* in dFB neurons (*23E10 \> trpA1* and *Gad1* RNAi; [Figure 7C, D and G](#fig7){ref-type="fig"}). In contrast, we still observed significant sleep-promoting effects resulting from TRPA1-induced activation of dFB neurons when we used RNAi to suppress production of other major neurotransmitters ([Figure 7H---J](#fig7){ref-type="fig"}). These results suggest that GABA is a necessary sleep-enhancing neurotransmitter synthesized in dFB neurons. This observation is in consistent with a previous report that dFB neurons communicate through inhibitory neurotransmitters and express the vesicular GABA transporter ([@bib15]).

![Sleep promotion due to hyperactivation of dFB neurons (*23E10-Gal4* positive) depends on GABA produced by dFB neurons.\
(**A---D**) Elevated sleep due to thermal hyperactivation of dFB neurons with TRPA1 (*23E10-Gal4* \> *trpA1*) is reduced by expression of the *Gad1* RNAi in dFB neurons. TRPA1 is activated at 29°C but not 22°C. (**E---J**) Quantification of total sleep-time at 22°C and 29°C exhibited by *23E10-Gal4* \> *trpA1* flies with or without RNAi transgenes directed at genes required for neurotransmitter synthesis or packaging. \*\*p \< 0.01. Paired Student's *t*-test. n = 24 for *23E10-Gal4*/+, n = 24 for *23E10-Gal4 \> trpA1* no RNAi, n = 13 for *23E10-Gal4 \> trpA1* and *Gad1* RNAi, n = 32 for *23E10-Gal4 \> trpA1* and *ChAT* RNAi, n = 28 for *23E10-Gal4 \> trpA1* and *VGlut* RNAi, and n = 9 for *23E10-Gal4 \> trpA1* and *VMAT* RNAi.](elife-40487-fig7){#fig7}

dFB sleep-promoting neurons inhibit arousal-promoting neurons {#s2-8}
-------------------------------------------------------------

Octopamine (OA) appears to increase wakefulness as nighttime sleep is reduced upon feeding flies OA ([@bib10]) or by activating tyrosine decarboxylase 2 (TDC2)-expressing neurons with NaChBac (*tdc2-Gal4 \> NaChBac*) ([@bib11]) ([Figure 8A](#fig8){ref-type="fig"}). Nighttime sleep in *tdc2-Gal4* \> *NaChBac* flies is fragmented as the number of sleep bouts increases dramatically, and the average length of each nighttime sleep bout is reduced greatly ([Figure 8B and C](#fig8){ref-type="fig"}).

![dFB neurons inhibit TDC2-positive arousal neurons.\
(**A---C**) Quantification of daytime and nighttime sleep parameters in flies expressing *UAS-NaChBac* under control of the *Tdc2-Gal4*. (**A**) Total sleep time. (**B**) Bout number. (**C**) Bout length. n = 24 for *UAS-NaChBac*/+, n = 16 for *Tdc2-Gal4*/+, n = 16 for *Tdc2* \>*NaChBac*. Error bars, SEMs. Unpaired Student's *t*-test. (**D**) A whole-mount brain co-expressing dFB and Tdc2 reporters (*23E10-Gal4 \> dsRed* and *Tdc2-LexA* \> *GFP*). The brain was co-stained with anti-dsRed and anti-GFP. The scale bar represents 40 µm. (**E**) Top, a whole-mount brain expressing *UAS-DenMark* and *UAS-syt-eGFP* under control of the *Tdc-Gal4*. The brain was co-stained with anti-dsRed (recognizes DenMark) and anti-GFP. The scale bar represents 40 µm. Bottom, images of the FB region showing the DenMark (anti-dsRed) and GFP signals separately. The boxed region contains the dFB. (**F**) Image of GRASP GFP fluorescence to test for close associations between Tdc2 and dFB neurons in the brain. The scale bar represents 60 µm. (**G**) Testing effect of GCaMP3 fluorescence in *Tdc2*-positive neurons after activating the P2X2 channel in dFB (*23E10-Gal4* positive) neurons with ATP. Representative images showing GCaMP3 fluorescence before and after bath application of 2.5 mM ATP. The scale bars represent 20 µm. (**H**) Representative traces showing the changes in GCaMP3 fluorescence (∆F/F0) upon bath application of 2.5 mM ATP. The genotype is the same as in (**G**).](elife-40487-fig8){#fig8}

We wondered whether dFB neurons might downregulate the activity of TDC2-positive arousal (OAA) neurons. We used two approaches to test for possible close associations between these two sets of neurons. First, we performed double-labeling experiments. The *tdc2-Gal4* reporter labeled neurons that project to multiple layers of the FB, including the dorsal layer where dFB neurons also project ([Figure 8D](#fig8){ref-type="fig"}). We then expressed dendritic (*UAS-DenMark*) and axonal (*UAS-syt::eGFP*) markers under control of the *tdc2-Gal4* to visualize potential input and output sites of the *Tdc2*-positive (OA) neurons. Most of the OA neuronal projections in the dFB were axonal (syt::eGFP; [Figure 8E](#fig8){ref-type="fig"}). In addition, there was a single dendritic layer in the dFB labeled with DenMark ([Figure 8E](#fig8){ref-type="fig"}). To determine whether dFB and OA neurons were in close contact, we performed GRASP analysis and observed signals in multiple areas of the brain. Of note, the OA neurons, which express the *Tdc2-Gal4*, form close connections with the dFB axonal terminals, which express *23E10* ([Figure 8F](#fig8){ref-type="fig"}).

To determine if activation of dFB neurons inhibited octopaminergic arousal (OAA) neurons, we expressed the ATP-activated cation channel P2X2 in dFB neurons and imaged OAA neuronal activity with GCaMP3. After applying ATP we observed a dramatic reduction in GCaMP3 fluorescence ([Figure 8G and H](#fig8){ref-type="fig"}). These data indicate that dFB sleep-promoting neurons inhibit OAA neurons.

Discussion {#s3}
==========

A regular sleep pattern is achieved through coordinated action of neuronal signals reflecting internal sleep needs, the circadian clock and the level of arousal. In *Drosophila*, neurons projecting to the dorsal fan-shaped body of the central complex (dFB neurons) are proposed to be the effectors of the sleep homeostat ([@bib14]; [@bib15]; [@bib32]; [@bib38]). In our study, we identified multiple sleep and arousal-promoting neurons, which regulate the activity of dFB neurons through direct synaptic connections onto either their dendritic or axonal terminals. One of two groups of sleep-promoting neurons is a set of circadian pacemaker neurons, referred to as LPN^AstA^ neurons. Thus, we propose that LPN^AstA^ are key neurons that provide circadian input to the dFB to influence sleep. Moreover, we found that artificial co-activation of sleep and arousal-promoting neurons lead to frequent shifts between sleep and wake states, indicating that temporal segregation of the activities of these regulatory neurons is necessary to maintain consolidated sleep. An important issue for future investigation concerns the relationship between the normal activity patterns of LPN^AstA^, dFB neurons and DAA neurons in live flies during sleep/wake conditions at different time during the circadian day/night cycles. The combination of highly sensitive, genetically encoded GCaMP sensors with an assay such as walking on an air supported ball should make this feasible ([@bib41]).

The NMDA receptor is proposed to promote sleep in *Drosophila* ([@bib40]; [@bib50]). Yet, the identity of the sleep-promoting glutaminergic synapse was unclear. Using the GRASP technique, we found that axons extending from both sets of sleep-promoting neurons (LPN^AstA^ and SLP^AstA^) form close associations with dendrites of dFB neurons in the SMP region. Furthermore, we demonstrated that glutamate is required in the LPN^AstA^ and SLP^AstA^ neurons to promote sleep and activate dFB neurons. We used ATP to activate LPN^AstA^ and SLP^AstA^ neurons expressing the P2X2 channel and found that this manipulation lead to increased activity of dFB neurons. The combination of these GRASP and activity data suggest the existence of glutaminergic synapses between LPN^AstA^/SLP^AstA^ and dFB neurons. However, our data do not distinguish which LPN^AstA^/SLP^AstA^ neurons are glutamatergic.

We found that the LPN circadian pacemaker neurons express AstA---a neuropeptide, which has been linked to sleep promotion ([@bib7]; [@bib15]). According to a previous model, AstA is released from dFB neurons since AstA is enriched at their axonal terminals, and an RNAi transgene targeting *AstA* in dFB neurons was reported to recapitulate the sleep reduction exhibited by an *AstA* loss-of-function allele ([@bib15]). However, the anti-AstA signal appeared to juxtapose rather than overlap the axonal terminal of dFB neurons, and evidence that dFB neurons actually express the AstA peptide was not presented ([@bib15]). Thus, AstA may be released by other neurons near the terminals of dFB neurons. Consistent with this possibility, we found that both LPN^AstA^ and SLP^AstA^ neurons are labeled by AstA reporter lines, and LPN^AstA^ neurons also express the AstA peptide. Our observations suggest that AstA released by LPN^AstA^ and/or SLP^AstA^ function as a sleep-promoting signal. Because dFB neurons are labeled by an *Allatostatin-A Receptor 1* (*AstAR1*) reporter, the AstA released by LPN^AstA^ and/or SLP^AstA^ neurons might act directly on the AstAR1 in dFB neurons. This possibility is supported by our GRASP analyses indicating that LPN^AstA^/SLP^AstA^ and dFB neurons are in close contact. AstAR1 has a role in promoting sleep ([@bib15]). However, it remains to be determined whether *AstAR1* is required in FB neurons for this sleep-promoting function.

Dopamine is an arousal neuromodulator in both fruit flies and mammals ([@bib3]; [@bib23]; [@bib31]; [@bib52]; [@bib53]). In flies, dopamine can switch dFB neurons from an active to a quiescent state ([@bib38]). In our study, we revealed a novel synaptic basis for dopaminergic regulation of dFB neurons. Our GRASP analyses reveal that dopaminergic arousal neurons (DAA) form close associations at various locations along the dendritic and axonal regions of dFB neurons. These include the SMP region where dFB neurons receive glutaminergic input. In addition, based on staining of dendritic and axonal makers, we propose that DAA neurons also form synapses with axons of dFB neurons in the dFB region. In support of this latter conclusion, we performed Ca^2+^imaging and found that dopamine downregulates Ca^2+^levels at the axonal terminals of dFB neurons. Thus, we propose that dopamine also contributes to arousal by suppressing the synaptic output from sleep promoting dFB neurons. dFB neurons receive both sleep-promoting glutaminergic and arousal-promoting dopaminergic inputs. Moreover, simultaneous activation of these opposing inputs by expressing *UAS-NaChBac* under control of the *TH-Gal4* and *65D05-Gal4* lines cause the flies to rapidly shift between sleep and wake states. Consequently, the animals are unable to experience long sleep bouts at night or stay awake for long periods during the day. These observations argue for a requirement for temporal segregation of input from sleep-promoting LPN^AstA^ and SLP^AstA^ neurons, and the arousal-promoting DAA neurons. While this approach enabled us to investigate the combined effects of sleep-promoting and arousal-promoting neurons on sleep it did not permit conclusions in terms of the precise dynamics of the shifts between sleep and wake states, as the *TH-Gal4* and *65D05-Gal4* lines presumably directs different levels of expression in the sleep- and arousal promoting neurons.

Our study also addressed the mechanism through which dFB neurons---the effectors of the sleep-homeostatic circuit, promote sleep. GABA is an inhibitory neurotransmitter and is known to promote sleep in flies and mammals ([@bib1]; [@bib8]; [@bib28]). We found that dFB neurons use GABA as their sleep-promoting neurotransmitter and that one of the downstream targets for dFB neurons are octopaminergic arousal-promoting (OAA) neurons. Based on GRASP analysis, we suggest that dFB neurons and OAA neurons form synapses. Because activating dFB neurons inhibits OAA neurons this inhibitory effect may serve to maintain long sleep bouts at night, since hyperactivation of OAA neurons causes fragmentation of nighttime sleep. Octopamine-producing neurons located in the medial protocerebrum are important for sleep ([@bib11]). However, it is unclear if these neurons are the OAA neurons downstream of dFB neurons.

Activation of dFB neurons inhibits the dopaminergic neurons that project to the mushroom bodies ([@bib4]). This inhibition was proposed to impair forgetting. Arousal dopaminergic neurons project to the dFB, rather than the mushroom bodies. However, the soma of these dopaminergic arousal neurons are distributed in the same location as the dopaminergic neurons that mediate forgetting. Therefore, future experiments using a specific reporter that only mark the DAA neurons will be needed to address if activation of dFB neurons also inhibits DAA neurons. Finally, given that the dFB region is part of the central complex, which integrates multiple types of sensory information ([@bib56]), we propose that the GABA released by dFB neurons may provide inhibitory modulation that increases the threshold for sensory responses in sleeping animals.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\               Designation                                   Source or\                             Identifiers                                                                   Additional\
  or resource                                                                         reference                                                                                                            information
  ------------------------------------- --------------------------------------------- -------------------------------------- ----------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Genetic reagent (*D. melanogaster*)   *UAS-NaChBac*                                 Bloomington Drosophila Stock Center    stock \# 9469; RRID:[BDSC_9469](https://scicrunch.org/resolver/BDSC_9469)     

  Genetic reagent (*D. melanogaster*)   *UAS-TetxLC.tnt*                              Bloomington Drosophila Stock Center    stock\# 28997; RRID:[BDSC_28997](https://scicrunch.org/resolver/BDSC_28997)   

  Genetic reagent (*D. melanogaster*)   *UAS-TrpA1(B).K*                              Bloomington Drosophila Stock Center    stock\# 26263; RRID:[BDSC_26263](https://scicrunch.org/resolver/BDSC_26263)   

  Genetic reagent (*D. melanogaster*)   *UAS-GCaMP6f*                                 Bloomington Drosophila Stock Center    stock\# 42747; RRID:[BDSC_42747](https://scicrunch.org/resolver/BDSC_42747)   

  Genetic reagent (*D. melanogaster*)   *VGlut-Gal80*                                 Bloomington Drosophila Stock Center    stock\# 58448; RRID:[BDSC_58448](https://scicrunch.org/resolver/BDSC_58448)   

  Genetic reagent (*D. melanogaster*)   *Tdc2-Gal4*                                   Bloomington Drosophila Stock Center    stock\# 9313; RRID:[BDSC_9313](https://scicrunch.org/resolver/BDSC_9313)      

  Genetic reagent (*D. melanogaster*)   *AstAR1-Gal4^23E10^*                          Bloomington Drosophila Stock Center    stock\# 49032; RRID:[BDSC_49032](https://scicrunch.org/resolver/BDSC_49032)   

  Genetic reagent (*D. melanogaster*)   *UAS-Shi^ts^*                                 Bloomington Drosophila Stock Center    stock\# 44222; RRID:[BDSC_44222](https://scicrunch.org/resolver/BDSC_44222)   

  Genetic reagent (*D. melanogaster*)   *Gad1-RNAi*                                   Bloomington Drosophila Stock Center    stock\# 28079; RRID:[BDSC_28079](https://scicrunch.org/resolver/BDSC_28079)   

  Genetic reagent (*D. melanogaster*)   *VMAT-RNAi*                                   Bloomington Drosophila Stock Center    stock\# 31257; RRID:[BDSC_31257](https://scicrunch.org/resolver/BDSC_31257)   

  Genetic reagent (*D. melanogaster*)   *hs-FLP*,*UAS-mCD8::GFP*                      Bloomington Drosophila Stock Center    stock\# 28832; RRID:[BDSC_28832](https://scicrunch.org/resolver/BDSC_28832)   

  Genetic reagent (*D. melanogaster*)   *lexAOp2-CsChrimson.mVenus*                   Bloomington Drosophila Stock Center    stock\# 55139; RRID:[BDSC_55139](https://scicrunch.org/resolver/BDSC_55139)   

  Genetic reagent (*D. melanogaster*)   *UAS-CsChrimson.mVenus*                       Bloomington Drosophila Stock Center    stock\# 55136; RRID:[BDSC_55136](https://scicrunch.org/resolver/BDSC_55136)   

  Genetic reagent (*D. melanogaster*)   *UAS-DenMark*,*UAS-syt.eGFP*                  Bloomington Drosophila Stock Center    stock\# 33064; RRID:[BDSC_33064](https://scicrunch.org/resolver/BDSC_33064)   

  Genetic reagent (*D. melanogaster*)   *UAS-mCD8-GFP*                                Bloomington Drosophila Stock Center    stock\# 5137; RRID:[BDSC_5137](https://scicrunch.org/resolver/BDSC_5137)      

  Genetic reagent (*D. melanogaster*)   *lexAOp2-Gal80*                               Bloomington Drosophila Stock Center    stock\# 32217; RRID:[BDSC_32217](https://scicrunch.org/resolver/BDSC_32217)   

  Genetic reagent (*D. melanogaster*)   *Tdc2-LexA*                                   Bloomington Drosophila Stock Center    stock\# 52242; RRID:[BDSC_52242](https://scicrunch.org/resolver/BDSC_52242)   

  Genetic reagent (*D. melanogaster*)   *AstAR1-LexA^23E10^*                          Bloomington Drosophila Stock Center    stock\# 53618; RRID:[BDSC_53618](https://scicrunch.org/resolver/BDSC_53618)   

  Genetic reagent (*D. melanogaster*)   *AstA-LexA^65D05^*                            Bloomington Drosophila Stock Center    stock\# 53625; RRID:[BDSC_53625](https://scicrunch.org/resolver/BDSC_53625)   

  Genetic reagent (*D. melanogaster*)   *ChAT-RNAi*                                   Bloomington Drosophila Stock Center    stock\# 60028; RRID:[BDSC_60028](https://scicrunch.org/resolver/BDSC_60028)   

  Genetic reagent (*D. melanogaster*)   *VGlut-RNAi*                                  BloomingtonDrosophila Stock Center     stock\# 40927; RRID:[BDSC_40927](https://scicrunch.org/resolver/BDSC_40927)   

  Genetic reagent (*D. melanogaster*)   *UAS-Clk.Δ*                                   Bloomington Drosophila Stock Center    stock\# 36318; RRID:[BDSC_36318](https://scicrunch.org/resolver/BDSC_36318)   

  Genetic reagent (*D. melanogaster*)   *AstA-Gal4^65D05^*                            Bloomington Drosophila Stock Center    stock\# 39351; RRID:[BDSC_39351](https://scicrunch.org/resolver/BDSC_39351)   

  Genetic reagent (*D. melanogaster*)   *UAS-mCD8-RFP, LexAOp2-mCD8-GFP*              Bloomington Drosophila Stock Center    stock\# 32229; RRID:[BDSC_32229](https://scicrunch.org/resolver/BDSC_32229)   

  Genetic reagent (*D. melanogaster*)   *TH-Gal4*                                     Bloomington Drosophila Stock Center    stock\# 8848; RRID:[BDSC_8848](https://scicrunch.org/resolver/BDSC_8848)      

  Genetic reagent (*D. melanogaster*)   *UAS-FRT-CD2-stop-FRT-mCherry::trpA1*         PMID: 24860455                                                                                                       

  Genetic reagent (*D. melanogaster*)   *UAS-P2X2,* lexOp-GCaMP3                      PMID: 22539819                                                                                                       

  Genetic reagent (*D. melanogaster*)   *UAS-cd4::spGFP1-10, lexAOp-cd4::spGFP11*     PMID: 19217375                                                                                                       

  Genetic reagent (*D. melanogaster*)   *AstA^LexA^*                                  This paper                                                                                                           

  Antibody                              anti-dsRed (rabbit polyclonal)                Takara                                 Cat. 632496                                                                   (1:1000)

  Antibody                              anti-GFP (rabbit polyclonal)                  ThermoFisher Scientific                Cat. A11122                                                                   (1:500)

  Antibody                              anti-GFP (chicken polyclonal)                 ThermoFisher Scientific                Cat. A10262                                                                   (1:1000)

  Antibody                              anti-GFP (mouse monoclonal)                   Sigma-Aldrich                          Cat. G6539                                                                    (1:100)

  Antibody                              anti-Brp (termed as nc82, mouse monoclonal)   Developmental Studies Hybridoma Bank   DHSB: nc82                                                                    (1:200)

  Antibody                              anti-Timeless (rat polyclonal)                other                                                                                                                Obtained from Amita Sehgal\'s lab; (1:1000)

  Antibody                              anti-TH (rabbit polyclonal)                   EMD Millipore                          Cat. AB152                                                                    (1:1000)

  Antibody                              anti-VGlut                                    other                                                                                                                Obtained from Aaron Dianonio\'s lab; (1:1000)

  Antibody                              anti-AstA (mouse monoclonal)                  Developmental Studies Hybridoma Bank   DHSB: 5F10                                                                    (1: 50)

  Antibody                              Goat anti-mouse IgG1                          ThermoFisher Scientific                                                                                              Alexa Fluor 488, 568, 647; (1:1000)

  Antibody                              Goat anti-rat IgG                             ThermoFisher Scientific                                                                                              Alexa Fluor 555; (1:1000)

  Antibody                              Goat anti-rabbit IgG                          ThermoFisher Scientific                                                                                              Alexa Fluor 488, 568; (1:1000)

  Antibody                              Goat anti-chicken                             ThermoFisher Scientific                                                                                              Alexa Fluor 488; (1:1000)

  Recombinant DNA reagent               pBPLexA::p65Uw                                Addgene                                Cat. 26231                                                                    pBPLexA::p65Uw was a gift from Gerald Rubin (Addgene plasmid \# 26231; <http://n2t.net/addgene>:26231; RRID:[Addgene_26231](https://scicrunch.org/resolver/Addgene_26231))

  Commercial assay or kit               In-Fusion cloning kit                         Takara                                 Cat. 121416                                                                   

  Chemical compound, drug               Mounting media                                Vector Laboratories                    Cat. H-1000                                                                   

  Chemical compound, drug               Triton X-100                                  Sigma-Aldrich                          Cat. T8787                                                                    

  Chemical compound, drug               L-glutamic Acid                               Sigma-Aldrich                          Cat. G1251                                                                    

  Chemical compound, drug               ATP                                           Sigma-Aldrich                          Cat. 10519987001                                                              

  Chemical compound, drug               Octopamine                                    Sigma-Aldrich                          Cat. O0250                                                                    

  Chemical compound, drug               Tyramine                                      Sigma-Aldrich                          Cat. T2879                                                                    

  Chemical compound, drug               Dopamine                                      Sigma-Aldrich                          Cat. H8502                                                                    

  Software, algorithm                   Sleeplab                                      other                                                                                                                shared by Dr. William Joiner

  Other                                 *Drosophila* Embryo Injection Services        BestGene Inc.                                                                                                        
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Drosophila* culture conditions {#s4-1}
-------------------------------

Flies (*Drosophila melanogaster*) were cultured on cornmeal-agar-molasses medium under 12 hr light/12 hr dark cycles at room-temperature and ambient humidity. Detailed information regarding specific stains and genotypes is provided in the Key Resources Table section.

Generation of *AstA^LexA^* flies {#s4-2}
--------------------------------

To generate the *AstA^LexA^* line with an insertion of the *LexA* reporter in place of endogenous AstA coding region (nucleotides 1--385 starting from endogenous start codon; [Figure 1G](#fig1){ref-type="fig"}), we used the CRISPR-HDR (clustered regularly interspaced short palindromic repeats -- homology directed repair) method. We chose upstream (5') and a downstream (3') guide RNAs using the CRISPR Optimal Target Finder: [http://tools.flycrispr.molbio.wisc.edu/targetFinder/](http://tools.flycrispr.molbio.wisc.edu/targetFinder/.). We annealed the following oligonucleotides to form two primer dimers. Each of the two primer dimers were cloned into the BbsI site of pU6-BbsI-ChiRNA (Addgene \#45946) to generate two guide RNA expression plasmids: pU6-BbsI-ChiRNA-*AstA*\_up, pU6-BbsI-ChiRNA-*AstA*\_down

*AstA*\_up_ChiRNA_For: CTTCGCAGTAGGAGGTGGGCGTGA,

*AstA*\_up_ChiRNA_Rev: CGTCATCCTCCACCCGCACTCAAA

*AstA*\_down_ChiRNA_For: CTTCTACTTGGCAGCCGAGCGTGC

*AstA*\_down_ChiRNA_Rev: ATGAACCGTCGGCTCGCACGCAAA

We amplified the *AstA* upstream (1.1 kb) and downstream (1.1 kb) homology arms using the following primers:

*AstA^LexA^* upstream_For: CCGAAAAGTGCCACCTGACGTAACAAGTATCTGGAGGCA

*AstA^LexA^* upstream_Rev: CTTCATTTTGATTGCTAGCGAAAAAGTCAGCGAAGACA

*AstA^LexA^* downstream_For: ACATACTAGGCGCGCCCATATCTACTGTGTTCCTTCCTTT

*AstA^LexA^* downstream_Rev: ATGTCGACAAGCCGAACATACACATAAATTCTTAGACCATG

We used the In-Fusion cloning kit (Clontech) to insert the upstream and downstream homology arms into the KpnI and NdeI sites of pBPLexA::p65Uw (Addgene \#26231), respectively (to create the pBPLexA::p65Uw-*AstA*\_LA + RA plasmid). The pU6-BbsI-ChiRNA-*AstA*\_up, pU6-BbsI-ChiRNA-*AstA*\_down, and pBPLexA::p65Uw-*AstA*\_LA + RA plasmids were injected into the BDSC \#51323 strain, which provided the source of Cas9 (BestGene Inc.).

Screening for RNAi lines that targets *VGlut, VMAT, ChAT and Gad1* {#s4-3}
------------------------------------------------------------------

To screen for RNAi lines that lead to effective gene silencing upon expression in neurons, we screened a panel of available TRiP RNAi lines designed against *VGlut, VMAT, ChAT and Gad1*. We crossed these RNAi lines with *UAS-Dicer;;elav-Gal4* flies, which lead to pan-neuronal expression of these RNAi transgenes. We then screened for lines that either lead to lethality (line BL60028 for *ChAT* RNAi and line BL28079 for *Gad1* RNAi) or a large reduction of the corresponding gene products measured by quantitative RT-PCR or immunohistochemistry ([Figure 4---figure supplement 1A---F](#fig4s1){ref-type="fig"})

Sleep behavior {#s4-4}
--------------

To measure sleep, we used 3---7 day-old female flies. Individual flies were loaded into glass tubes (provided with the Drosophila Activity Monitoring system (TriKinetics Inc.). The tubes each contained 5% sucrose and 1% agarose as the food source at one end and a small cotton plug at the other end. Flies were entrained for ≥2 days before activity data were collected for analysis. The activity data were collected in one-minute bins for further processing using MATLAB (MathWorks)-based software ([@bib30]). If no activity was detected by the Drosophila Activity Monitoring system for more than 5 min, the fly was considered to be in a sleep state. Sleep assays were performed under white LED lights during the light period at 25°C unless otherwise indicated. For optogenetic stimulation, flies were cultured in regular food supplied with all-*trans* retinal in the dark for 24 hr before loading the animals into the glass tubes to perform activity measurements.

To test arousal, flies were maintained for 5 days under 12 hr light/12 hr dark cycles. On the 5^th^ night, 5 min light pulses were delivered at ZT16, ZT18, and ZT20. To analyze the effects of the nighttime light stimuli on arousal, we quantified total sleep during the 30 min period beginning with the 5 min light stimuli and continuing an additional 25 min.

Activation of neurons using optogenetics and thermogenetics {#s4-5}
-----------------------------------------------------------

To measure sleep upon optogenetic stimulation, we used 3---7 day-old female flies. Flies were cultured in regular food supplied with all-*trans* retinal in the dark for 24 hr before loading individual flies into the same type of glass tubes mentioned above. The tubes contained 5% sucrose and 1% agarose as the food source at one end and a small cotton plug at the other end. Flies were entrained for 3 days under blue LED lights. On the 4^th^ day, the LED lights were switched to red. Activity data were collected in one-minute bins for further processing using Sleep-Lab software. The effects on sleep as a result of optogenetic activation of neurons were quantified as the sleep change under red lights on day four verses blue lights on day 3.

We used the heat-activated channel, TRPA1, in combination with the *Gal4*/*UAS* system to activate neurons. To conduct these analyses, we introduced 3---7 day old female flies that were cultured on standard food into TriKinetics glass tubes with 5% sucrose +1% agarose as the food source at one end and a small cotton plug at the other end. Flies were entrained for 3 days under white LED lights at 22°C and the temperature was switched to 29°C on the day four to activate TRPA1. Activity data were collected in one-minute bins for further process using MATLAB-based software ([@bib27]). The effects on sleep as a result of thermogenetic manipulation of neuronal activity were quantified as the sleep change (in minutes) at 29°C (4^th^ day) verses 22°C (3^rd^ day).

Whole-mount brain immunohistochemistry {#s4-6}
--------------------------------------

For whole-mount brain immunohistochemistry, brains were dissected in phosphate buffered saline and 0.3% Triton X-100 (PBST). The brains were fixed with 4% paraformaldehyde (PFA) in PBST at room temperature for 20 min. Brains were briefly washed two times in PBST, blocked with PBST and 5% normal goat serum (NGS) at 4°C for 1 hr, and incubated overnight with primary antibodies diluted in PBST and 5% NGS at the following dilutions: 1) (1:1000) chicken anti-GFP, rabbit anti-dsRed, rabbit anti-TH antibody, and rat anti-Timeless, 2) (1:500) rabbit anti-GFP, 3) (1:200) nc82, 4) mouse anti-GFP antibody (1:100), and 5) (1:50) mouse anti-AstA. After three washes in PBST, we incubated the brains overnight in secondary antibodies corresponding to the primary antibodies used. Secondary antibodies were diluted 1:1000 in PBST and 5% NGS (refer to the Key Resource Table for the list of secondary antibodies). The brains were washed three times in PBST, and mounted in VECTASHIELD (Vector Laboratories) on glass slides. Images were acquired with an upright Zeiss LSM 700 confocal microscope using 20X, 40X (oil) or 63X (oil) lenses.

Mosaic expression of *mCherry::trpA1* using the *FlpOut* method {#s4-7}
---------------------------------------------------------------

To use mCherry::TRPA1 to activate different subsets of neurons that express the *AstA-Gal4*, we conducted a mosaic analysis to express *mCherry::trpA1* in random subsets of *AstA-Gal4* neurons. To do so, we combined *hs-Flp* and *AstA-Gal4* transgenes with the *UAS-mCD8::GPF* transgene, and the *UAS-FRT-CD2-stop-FRT-mCherry::trpA1* transgene ([@bib54]). The animals were maintained at room temperature (\~22°C). To remove the *stop* cassette, we induced *hs-FLP* expression by heat shocking 3^rd^ instar larval at 37°C for 1 hr. The animals were then returned to room temperature (\~22°C) after the heat shock. We refer to these animals as *AstA \>FlpOut-mCherry::trpA1* flies. We used 3---7 day-old female *AstA \>FlpOut-mCherry::trpA1* flies to conduct the sleep measurements following the thermogenetic procedure described above. To tabulate the percentage of flies with a given amount of sleep change due to thermal activation of mCherry::TRPA1, we used the following calculation: sleep at 29°C minus sleep at 22°C.

To image the neurons, we dissected the brains of *AstA \>FlpOut-mCherry::trpA1* flies that showed either sleep-promoting effects (sleep change \>100 min) and that did not show sleep-promoting effects (sleep change \<100 min). We then stained the brains with anti-GFP and anti-dsRed as described above (see Whole-mount Brain Immunohistochemistry).

GRASP analyses {#s4-8}
--------------

To conduct the GRASP analyses ([@bib16]; [@bib17]), we expressed *lexAOp-CD4::spGFP^11^* and *UAS-CD4::spGFP^1-10^*under control of the *23E10* (*AstAR1*)*-LexA* and either the *65D05* (*AstA-Gal4*) or the *TH-Gal4*.To image GRASP signals, the brains were dissected in PBST, fixed with 4% PFA in PBST at room temperature for 20 min, and briefly washed with PBST before mounting in VECTASHIELD (Vector Laboratories) and viewing the fluorescence. To enhance GRASP signals, we performed immunostaining using mouse anti-GFP.

Ca^2+^ imaging in brains {#s4-9}
------------------------

To perform Ca^2+^imaging on whole-mount brains, expressing GCaMP3, GCaMP6f or syt::GCaMP6s, the flies were anaesthetized on ice and the brains were dissected into AHL buffer (108 mM NaCl, 5 mM KCl, 8.2 mM MgCl~2~, 2 mM CaCl~2~, 4 mM NaHCO~3~, 1 mM NaH~2~PO~4~, 5 mM trehalose, 5 mM sucrose, and 5 mM HEPES pH 7.5), and transferred to an imaging chamber with a glass bottom, which was made from cover slides. The brains were immobilized with a metal harp and imaged using an inverted Zeiss LSM 800 confocal microscope. The regions of interest in the soma and neuronal processes were scanned in the time-lapse mode using 4---6 Z stacks. 30 or more cycles (60---90 s total) were imaged for checking the stability of the sample in the imaging chamber prior to adding chemicals to the bath. The average intensity during the last 10 of these 30 pre-cycles (before adding the chemicals) was used as the baseline (F) to calculate ΔF.

Quantification and statistical analyses {#s4-10}
---------------------------------------

No statistical method was applied to compute sample sizes when the study was designed. An appropriate sample size was adopted empirically according to published studies in the same field. No outlier data points were excluded in the statistical analyses. Animals were randomly selected into experimental groups. No masking was applied during group allocation, data collection and analysis.

To analyze sleep behavior, multiple animals were tested and the sleep index of individual animals were quantified independently. The numbers of animals tested were all biological replicates (each biological replicate was an independent individual animal) with numbers (n) indicated in all figure legends. For quantification of real-time PCR, each biological replicate was a sample of total RNA extracted from 10 animals of the indicated genotype. We used Student's *t*-tests to compare two group of samples. In most cases the tests were unpaired. We used paired Student's *t*-tests for comparing the effects of thermogenetic activation with TRPA1 in [Figure 7](#fig7){ref-type="fig"}. For comparing multiple groups, we used one-way ANOVA followed by the Dunnett test. Error bars indicate SEMs with indicated p values for statistical analysis. \* Indicates p\<0.05 and \*\* indicates p\<0.01.
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Reviewing Editor
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Ireland

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Differential regulation of the *Drosophila* sleep homeostat by circadian and arousal inputs\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Mani Ramaswami as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by a Reviewing Editor and Eve Marder as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Alex C Keene (Reviewer \#2); Paul Shaw (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This is an exciting manuscript that further dissects the circuitry underlying sleep/wake regulation. Here, the authors map sleep and wake promoting neural circuitry that innervates the dorsal fan-shaped body, a critical regulator of sleep. In addition, the paper identifies neurotransmitters that function within this circuitry. The identification of LPN/SLP neurons as modulators of dFB function, and potential integrators of sleep and the circadian clock is a significant advance for the field, providing mechanistic insight into how sleep need is detected, and subsequently regulated. The authors also examine the role of dopamine neurons on sleep regulation, though this component of the manuscript is less novel. They further provide data indicating that dFB neurons release the neurotransmitter GABA to inhibit octopaminergic arousal neurons.

A strength of the manuscript are the complementary application of genetic manipulations and functional imaging to map sleep associated circuits. Overall, the manuscript is well written, with robust findings. The data are clearly presented, and their interpretation is supported by the data.

There are, however, a number of weaknesses most of which can be addressed without need for further experiments. The manuscript will be greatly improved by streamlining and moderating the presentation, with a greater effort to place the findings within the current literature and define sleep.

Essential revisions:

1\) The current findings do not show the LPNs integrate sleep and the circadian clock. The fact that LPNs express clock genes does not necessarily indicate a role in circadian-regulation of sleep. How does perturbing a central clock component (Per/Tim or one another) in LPN^AstA^ neurons influence sleep? This is an obvious experiment to test and strengthen the interesting hypothesis that these neurons provide circadian input to sleep behavior.

2\) The authors do not cite the original paper identifying the dFB as being sleep-promoting (Donlea et al., 2011). This oversight highlights a major concern that the authors do not show that the increased quiescence in *65D05\>NaChBac* meets the criteria for sleep. In the original 2011 dFB paper, sleep was confirmed by examining arousal thresholds and sleep homeostasis as well as a host of other variables. But when new genetic manipulations are found to increase quiescence, one cannot simply assume that it is sleep, one must also determine whether the quiescence meets the other criteria. Arousal thresholds are relatively easy to quantify, and several labs have used a variety of techniques that do a nice job of measuring arousal thresholds. Sleep homeostasis is also a common tool used by a large number of *Drosophila* sleep labs and the authors should be able to quickly evaluate homeostasis. The DART system is a cheap and inexpensive way to monitor both. Quantifying arousal thresholds and homeostasis in the *65D05\>NaChBac* flies and their parental controls. These analyses should be added to a revised manuscript.

3\) The summary statement and description of the dFB in the text is slightly misleading. The literature suggests that it remains controversial whether dFB is "the" output arm of the homeostat (see Liu et al., 2016 and Seidner et al., 2015). It is likely one of many outputs, as evidence supports EB neurons, and non-central complex neurons are involved in homeostasis and sleep regulation. My understanding of the literature is there is not a singular sleep center, and it is likely regulated (in flies and mammals) by dispersed circuit connectivity.

4\) The data presentation should be improved and better aligned with the existing literature. Traditionally, sleep traces over the 24 hour day for both parental controls (*UAS/+* and *Gal4/+* are plotted on the same graph as the experimental line (*Gal4\>UAS*) so that they can be directly compared. However, the authors have decided to only show one genotype on each graph. This approach makes it very difficult to determine exactly what happened. Moreover, the authors don\'t show all of the parental lines in the main text. It turns out that the only way for a reader to fully understand how the experimental line behaves is to compare it directly to both parental lines. Are the sleep traces depicted for the experimental lines and parental lines from the same experiment? Do the experimental lines show an odd pattern of sleep? The data would be much easier to understand and interpret if the authors compared the experimental line directly to both parental lines in the same graph.

5\) In the same vein, it is worth noting, the authors do plot multiple genotypes on the same graph when they want to emphasize a difference (e.g. Figure 6A). However, the authors are selective in which parental line to us. For example, the authors show the *UAS-NaChBac*/+ controls in Figure 6 without showing the *Gal4*/+ for comparison but show the *Tdc2-Gal4*/+ in Figure 8 without showing the *UAS-NaChBac*/+. Was sleep only evaluated once for the *UAS-NaChBac*/+ group? Plotting the full experiment together eliminates these questions. Indeed, in Figure 6, *65D05*/+ and *TH-Gal4*/+ seem to be missing from the analysis. It is inappropriate and misleading to make a comparison between an experimental line and just one of the two parental lines. Both comparisons are required.

6\) Regarding the co-activation experiments, there are a number of implicit assumptions in how this approach may or may not work. The interpretation of the dataset may not be as straightforward as presented. The manuscript would be greatly improved if the authors devote space in the Discussion section on the strengths and pitfalls of this approach. For example, is it obvious that *TH-Gal4* results in the same level of Gal4 expression as *65D05-Gal4*? If the expression levels are different, how would this alter the interpretation of the results?

7\) The images shown throughout the manuscript are very nice. Is there a reason that we don\'t see the merge for Figure 2D-I?

8\) How closely does the expression patter of the *65D05-LexA* driver match the expression pattern of *65D05-Gal4*? This should be shown and described.

9\) Overall, the imaging experiments and circuit experiments rely on ectopic manipulation of neural activity. This means limited inferences can be drawn about the activity of these circuits under endogenous sleep-wake conditions. With current behavioral technology (for example, fly-ball trackers) this can be addressed. It would be useful to comment on this in the Discussion section.

10\) As an extension of the previous point, changes in dFB when modulated putatively upstream neurons to not mean these neurons are directly acting on the dFB, but simply are part of the circuit.

11\) The presentation of Figure 1J is confusing. It may be improved by adding genotypes above the graphs (as in Figure 1A-C) and using different colors to depict light protocol from those used to depict genotype.

12\) Are LPN^AstA^ and SLP^AstA^ neurons glutamatergic and is *VGlut* required in LPN^AstA^ cells? The limitations of the existing data should be acknowledged or extended.

13\) Is AstA required in these AstA neuronal populations? If this is not known, then the issue should be addressed or formally acknowledged.

14\) Similarly, is AstAR1 required in FB neurons?

15\) Is there a really a population of AstA expressing neurons adjacent to sleep promoting, AstA-receptor expressing FB neurons in the fan-shaped body as suggested? Instead of using Gal4 or reporter lines, can these issues be addressed using antibody staining? Do these neurons play any role in sleep control? This should be discussed.

16\) Has previous work shown that inhibition of OAA neurons increases arousal threshold? This is implied as the likely reason for FB\>OAA connectivity. Also, is it known how OAA neurons connect to the FB? Please clarify.

17\) Does FB neuron activation also inhibit DAA neurons? Is this known and/or can it be determined or discussed?

18\) The authors cite Berry et al. (2015) in relation to the role of the dFB and sleep homeostasis but the focus of the paper was on forgetting.

19\) The authors cite Hendricks et al. (2000) for determining that a 5 minute bin was used to define sleep even though the group used a 30 minute bin until 2003; the first mention of a 5 minute bin was in 2000.

10.7554/eLife.40487.020

Author response

> Essential revisions:
>
> 1\) The current findings do not show the LPNs integrate sleep and the circadian clock. The fact that LPNs express clock genes does not necessarily indicate a role in circadian-regulation of sleep. How does perturbing a central clock component (Per/Tim or one another) in LPN^AstA^ neurons influence sleep? This is an obvious experiment to test and strengthen the interesting hypothesis that these neurons provide circadian input to sleep behavior.

To test for a potential contribution of the central clock for the sleep-promoting function of LPN^AstA^ neurons we expressed a dominate-negative isoform of the central clock component, Clock (*UAS-Clk∆*) in LPN^AstA^ neurons under control of the *65D05-Gal4*. We found that the sleep-promoting effect due to neuronal hyperactivation of LPN^AstA^ neurons (*65D05-Gal4\>NaChBac*) during the daytime was reduced by expression of *Clk∆* (Figure 4---figure supplement 2A and B). This indicates that the central clock in LPN^AstA^ neurons contributes to the sleep-promoting function of these neurons. We describe these data in subsection "Sleep-promoting role of AstA and a central clock component in LPN^AstA^ neurons".

> 2\) The authors do not cite the original paper identifying the dFB as being sleep-promoting (Donlea et al., 2011). This oversight highlights a major concern that the authors do not show that the increased quiescence in 65D05\>NaChBac meets the criteria for sleep. In the original 2011 dFB paper, sleep was confirmed by examining arousal thresholds and sleep homeostasis as well as a host of other variables. But when new genetic manipulations are found to increase quiescence, one cannot simply assume that it is sleep, one must also determine whether the quiescence meets the other criteria. Arousal thresholds are relatively easy to quantify, and several labs have used a variety of techniques that do a nice job of measuring arousal thresholds. Sleep homeostasis is also a common tool used by a large number of Drosophila sleep labs and the authors should be able to quickly evaluate homeostasis. The DART system is a cheap and inexpensive way to monitor both. Quantifying arousal thresholds and homeostasis in the 65D05\>NaChBac flies and their parental controls. These analyses should be added to a revised manuscript.

We added the Donlea et al. (2011) reference in the first paragraph of the Introduction. To test the effects of activating dFB neurons on arousal threshold we maintained the flies for five days under 12 hour light/12 hour dark cycles. On the fifth night, we exposed the flies to three light-pulses (5-min each delivered at ZT16, ZT18, and ZT20; Figure 1---figure supplement 1A). In control flies (*65D05-Gal4/+* and *UAS-NaChBac/+),* the light stimuli caused large reductions in sleep during the 30-minute period following the onset of the light stimuli (Figure 1---figure supplement 1B-D). However, the *65D05\>NaChBac* flies, did not exhibit decreased sleep (arousal) in response to the 5 minute light stimulations (Figure 1---figure supplement 1B and E). These data support the proposal thathyperactivationof dFB neurons increases sleep. We described these new results in the Results section.

> 3\) The summary statement and description of the dFB in the text is slightly misleading. The literature suggests that it remains controversial whether dFB is "the" output arm of the homeostat (see Liu et al., 2016 and Seidner et al., 2015). It is likely one of many outputs, as evidence supports EB neurons, and non-central complex neurons are involved in homeostasis and sleep regulation. My understanding of the literature is there is not a singular sleep center, and it is likely regulated (in flies and mammals) by dispersed circuit connectivity.

In response to this comment, we slightly modified the first sentence of the abstract from "*The* output arm of the sleep homeostat in *Drosophila is* a group of neurons with projections to the dorsal fan-shaped body (dFB neurons) of the central complex in the brain" to "*One* output arm of the sleep homeostat in *Drosophila appears to be* a group of neurons with projections to the dorsal fan-shaped body (dFB neurons) of the central complex in the brain."

In addition, we added the following sentence to the Introduction:

"Other non-central complex neurons are also involved in sleep regulation and different neuronal pathways elicit distinct effects on the sleep homeostat (Seidner et al., 2015)."

> 4\) The data presentation should be improved and better aligned with the existing literature. Traditionally, sleep traces over the 24 hour day for both parental controls (UAS/+ and Gal4/+ are plotted on the same graph as the experimental line (Gal4\>UAS) so that they can be directly compared. However, the authors have decided to only show one genotype on each graph. This approach makes it very difficult to determine exactly what happened. Moreover, the authors don\'t show all of the parental lines in the main text. It turns out that the only way for a reader to fully understand how the experimental line behaves is to compare it directly to both parental lines. Are the sleep traces depicted for the experimental lines and parental lines from the same experiment? Do the experimental lines show an odd pattern of sleep? The data would be much easier to understand and interpret if the authors compared the experimental line directly to both parental lines in the same graph.

The experimental and parental lines were conducted in the same experiments. We have now added combined graphs to simplify comparisons, although in most cases we also include the separate graphs so that the individual graphs can be viewed with clarity.

> 5\) In the same vein, it is worth noting, the authors do plot multiple genotypes on the same graph when they want to emphasize a difference (e.g. Figure 6A). However, the authors are selective in which parental line to us. For example, the authors show the UAS-NaChBac/+ controls in Figure 6 without showing the Gal4/+ for comparison but show the Tdc2-Gal4/+ in Figure 8 without showing the UAS-NaChBac/+. Was sleep only evaluated once for the UAS-NaChBac/+ group? Plotting the full experiment together eliminates these questions. Indeed, in Figure 6, 65D05/+ and TH-Gal4/+ seem to be missing from the analysis. It is inappropriate and misleading to make a comparison between an experimental line and just one of the two parental lines. Both comparisons are required.

We added analyses of the *65D05-Gal4*/+ and the *TH-Gal4*/+ to Figure 6. We added the *UAS-NaChBac*/+ control to Figure 8.

> 6\) Regarding the co-activation experiments, there are a number of implicit assumptions in how this approach may or may not work. The interpretation of the dataset may not be as straightforward as presented. The manuscript would be greatly improved if the authors devote space in the Discussion section on the strengths and pitfalls of this approach. For example, is it obvious that TH-Gal4 results in the same level of Gal4 expression as 65D05-Gal4? If the expression levels are different, how would this alter the interpretation of the results?

This is a valid point. To alert the reader to the limitation of this approach, we added the following point to the Discussion section:

"While this approach enabled us to investigate the combined effects of sleep-promoting and arousal-promoting neurons on sleep it did not permit conclusions in terms of the precise dynamics of the shifts between sleep and wake states, as the *TH-Gal4* and *65D05-Gal4* lines presumably directs different levels of expression in the sleep- and arousal promoting neurons."

> 7\) The images shown throughout the manuscript are very nice. Is there a reason that we don\'t see the merge for Figure 2D-I?

We added the merge images to Figure 2.

> 8\) How closely does the expression patter of the 65D05-LexA driver match the expression pattern of 65D05-Gal4? This should be shown and described.

To address this question, we performed double-labeling experiments using *lexAop-mCD8::GFP* and *UAS-mCD8::RFP* expressed under control of the *65D05-Gal4* and *65D05-LexA*, respectively. We found that the two reporters largely labeled the same sets of neurons in the fly brain (Figure 3---figure supplement 2). Of particular importance to our work, both the *LexA* and *Gal4* reporters labeled the SLP^AstA^ (Figure 3---figure supplement 2A-C) and LPN^AstA^ neurons (Figure 3---figure supplement 2D-F and the Results section).

> 9\) Overall, the imaging experiments and circuit experiments rely on ectopic manipulation of neural activity. This means limited inferences can be drawn about the activity of these circuits under endogenous sleep-wake conditions. With current behavioral technology (for example, fly-ball trackers) this can be addressed. It would be useful to comment on this in the Discussion section.

We added this point to the Discussion section.

> 10\) As an extension of the previous point, changes in dFB when modulated putatively upstream neurons to not mean these neurons are directly acting on the dFB, but simply are part of the circuit.

We suggest the combination of activating upstream neurons combined with GRASP experiments allow us to "suggest" direct interactions. We expanded the second paragraph of the Discussion section to make this point.

"The NMDA receptor is proposed to promote sleep in *Drosophila* (Robinson et al., 2016; Tomita et al., 2015). \[...\] The combination of these GRASP and activity data suggest the existence of glutaminergic synapses between LPN^AstA^/SLP^AstA^ and dFB neurons."

> 11\) The presentation of Figure 1J is confusing. It may be improved by adding genotypes above the graphs (as in Figure 1A-C) and using different colors to depict light protocol from those used to depict genotype.

We modified Figure 1 as suggested.

> 12\) Are LPN^AstA^ and SLP^AstA^ neurons glutamatergic and is VGlut required in LPN^AstA^ cells? The limitations of the existing data should be acknowledged or extended.

Our data support the conclusion that at least some LPN^AstA^ and SLP^AstA^ neurons are glutamatergic. Specifically, we found that the sleep-promoting effect due to expression of NaChBac in LPN^AstA^ and SLP^AstA^ neurons (*65D05-Gal4\>NaChBac*) is suppressed by RNAi knock down of the vesicular glutamate transporter (*VGlut;* Figure 4A, E and F). However, our data do not distinguish which LPN^AstA^/SLP^AstA^ neurons are glutamatergic. We now acknowledge this limitation in the Discussion section.

> 13\) Is AstA required in these AstA neuronal populations? If this is not known, then the issue should be addressed or formally acknowledged.

To address whether AstA functions in LPN^AstA^ neurons to promote sleep, we conducted additional experiments. We examined whether removal of AstA impacted on the sleep-promoting effect induced by hyperactivation of these neurons (*65D05-Gal4\>NaChBac*). We found that the *AstA^LexA^* mutation significantly decreased the sleep-promoting effect caused by expression of NaChBac (Figure 4---figure supplement 2C and D). The reduction in sleep due to the *AstA^LexA^* mutation was most pronounced during the second half of the daytime period. These data are now described in subsection" Sleep-promoting role of AstA and a central clock component in LPN^AstA^ neurons".

> 14\) Similarly, is AstAR1 required in FB neurons?

Unfortunately, the reagents necessary to address this question are not available to us and we could not obtain them in a timely fashion. We added the following to the Discussion section to clarify this point:

"Because dFB neurons are labeled by an *Allatostatin-A Receptor 1 (AstAR1*) reporter, the AstA released by LPN^AstA^ and/or SLP^AstA^ neurons might act directly on the AstAR1 in FB neurons. Moreover, AstAR1 has a role in promoting sleep (Donlea et al., 2018). However, it remains to be determined whether *AstAR1* is required in FB neurons for this sleep-promoting function."

> 15\) Is there a really a population of AstA expressing neurons adjacent to sleep promoting, AstA-receptor expressing FB neurons in the fan-shaped body as suggested? Instead of using Gal4 or reporter lines, can these issues be addressed using antibody staining? Do these neurons play any role in sleep control? This should be discussed.

AstA-receptor antibodies are not available. AstA antibodies are available and stain LPN^AstA^ neurons (Figure 2J). However, the projections of LPN^AstA^ neurons are visualized more clearly with the *AstA^LexA^* reporter (*AstA^LexA^\>GFP*). These projections extend to the SMP region (Figure 3G) and form potential synapses with dFB neurons, which are labeled by the AstAR1 reporter, *23E10-Gal4*. Thus, these AstA and AstAR1 neurons are potentially adjacent. This proposal is further supported by the results of our GRASP analysis (Figure 3J). This is described in the Discussion section:

"...we found that both LPN^AstA^ and SLP^AstA^ neurons are labeled by AstA reporter lines, and LPN^AstA^ neurons also express the AstA peptide. Our observations suggest that AstA released by LPN^AstA^ and/or SLP^AstA^ function as a sleep-promoting signal. Because dFB neurons are labeled by an *Allatostatin-A Receptor 1 (AstAR1*) reporter, the AstA released by LPN^AstA^ and/or SLP^AstA^ neurons might act directly on the AstAR1 in FB neurons. This possibility is supported by our GRASP analyses indicating that LPN^AstA^/SLP^AstA^ and dFB neurons are in close contact."

> 16\) Has previous work shown that inhibition of OAA neurons increases arousal threshold? This is implied as the likely reason for FB\>OAA connectivity. Also, is it known how OAA neurons connect to the FB? Please clarify.

Previous experiments on OAA neurons focused on activation rather than inhibition of OAA neurons. This manipulation reduced sleep and caused a consequent reduction in arousal threshold (Crocker and Sehgal, 2010). Presumably, inhibition of OAA neurons would increase arousal threshold. However, this has not been demonstrated experimentally. In the Discussion section, we comment on the implication of the FB to OAA connectivity:

"Because activating dFB neurons inhibits OAA neurons, this inhibitory effect may serve to maintain long sleep bouts at night since hyperactivation of OAA neurons causes fragmentation of nighttime sleep. Octopamine-producing neurons located in the medial protocerebrum are important for sleep (Crocker et al., 2010). However, it is unclear if these neurons are the OAA neurons downstream of dFB neurons."

> 17\) Does FB neuron activation also inhibit DAA neurons? Is this known and/or can it be determined or discussed?

Berry et al. (2015) found that FB neurons inhibit DAA neurons that project to the mushroom bodies, and they propose that this inhibition impairs dopamine-mediated forgetting. Arousal DAA neurons project to the FB, rather than the mushroom bodies. However, the soma of these dopaminergic arousal neurons are distributed in the same location as the dopaminergic neurons that mediate forgetting. Therefore, future experiments using a specific reporter that only mark the DAA neurons will be needed to address if FB neuron activation also inhibits DAA neurons. We modified our Discussion section.

> 18\) The authors cite Berry et al. (2015) in relation to the role of the dFB and sleep homeostasis but the focus of the paper was on forgetting.

We changed the citation of Berry et al. (2015) to Donlea et al. (2011).

> 19\) The authors cite Hendricks et al. (2000) for determining that a 5 minute bin was used to define sleep even though the group used a 30 minute bin until 2003; the first mention of a 5 minute bin was in 2000.

We made the correction.
